These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
379 related articles for article (PubMed ID: 27460622)
1. Dose Equivalents for Antipsychotic Drugs: The DDD Method. Leucht S; Samara M; Heres S; Davis JM Schizophr Bull; 2016 Jul; 42 Suppl 1(Suppl 1):S90-4. PubMed ID: 27460622 [TBL] [Abstract][Full Text] [Related]
2. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020. Yıldız M; Osman E Turk Psikiyatri Derg; 2022; 33(2):146-148. PubMed ID: 35730516 [TBL] [Abstract][Full Text] [Related]
3. Dose equivalents for second-generation antipsychotics: the minimum effective dose method. Leucht S; Samara M; Heres S; Patel MX; Woods SW; Davis JM Schizophr Bull; 2014 Mar; 40(2):314-26. PubMed ID: 24493852 [TBL] [Abstract][Full Text] [Related]
4. Dose Equivalents for Second-Generation Antipsychotic Drugs: The Classical Mean Dose Method. Leucht S; Samara M; Heres S; Patel MX; Furukawa T; Cipriani A; Geddes J; Davis JM Schizophr Bull; 2015 Nov; 41(6):1397-402. PubMed ID: 25841041 [TBL] [Abstract][Full Text] [Related]
5. Dose equivalents for second generation long-acting injectable antipsychotics: The minimum effective dose method. Rothe PH; Heres S; Leucht S Schizophr Res; 2018 Mar; 193():23-28. PubMed ID: 28735640 [TBL] [Abstract][Full Text] [Related]
6. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation]. Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I Encephale; 2005; 31(2):235-46. PubMed ID: 15959450 [TBL] [Abstract][Full Text] [Related]
11. Chlorpromazine equivalents versus defined daily doses: how to compare antipsychotic drug doses? Rijcken CA; Monster TB; Brouwers JR; de Jong-van den Berg LT J Clin Psychopharmacol; 2003 Dec; 23(6):657-9. PubMed ID: 14624195 [TBL] [Abstract][Full Text] [Related]
12. Optimal Doses of Specific Antipsychotics for Relapse Prevention in a Nationwide Cohort of Patients with Schizophrenia. Taipale H; Tanskanen A; Luykx JJ; Solmi M; Leucht S; Correll CU; Tiihonen J Schizophr Bull; 2022 Jun; 48(4):774-784. PubMed ID: 35524479 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of Defined Daily Dose, percentage of British National Formulary maximum and chlorpromazine equivalents in antipsychotic drug utilization. Sweileh WM; Odeh JB; Shraim NY; Zyoud SH; Sawalha AF; Al-Jabi SW Saudi Pharm J; 2014 Apr; 22(2):127-32. PubMed ID: 24648824 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of safety warnings in atypical antipsychotic drugs: an interrupted time-series analysis in Spain. Sanfélix-Gimeno G; Cervera-Casino P; Peiró S; López-Valcarcel BG; Blázquez A; Barbera T Drug Saf; 2009; 32(11):1075-87. PubMed ID: 19810779 [TBL] [Abstract][Full Text] [Related]
15. Is the Defined Daily Dose system a reliable tool for standardizing antipsychotic dosages? Nosè M; Tansella M; Thornicroft G; Schene A; Becker T; Veronese A; Leese M; Koeter M; Angermeyer M; Barbui C Int Clin Psychopharmacol; 2008 Sep; 23(5):287-90. PubMed ID: 18703938 [TBL] [Abstract][Full Text] [Related]
16. Chlorpromazine versus atypical antipsychotic drugs for schizophrenia. Saha KB; Bo L; Zhao S; Xia J; Sampson S; Zaman RU Cochrane Database Syst Rev; 2016 Apr; 4(4):CD010631. PubMed ID: 27045703 [TBL] [Abstract][Full Text] [Related]
18. Olanzapine versus other atypical antipsychotics for schizophrenia. Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Duggan L; Kissling W; Leucht S Cochrane Database Syst Rev; 2010 Mar; (3):CD006654. PubMed ID: 20238348 [TBL] [Abstract][Full Text] [Related]
19. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis. Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482 [TBL] [Abstract][Full Text] [Related]
20. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine. Krzystanek M; Krupka-Matuszczyk I Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]